Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
- Details
- Category: Product
![Forest Laboratories, Inc. Forest Laboratories, Inc.](http://www.worldpharmanews.com/images/stories/logo/forest.gif)
The Bayer Group once again considerably improved its sales and earnings in 2007
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Celebrity Chef Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Company Bristol-Myers Squibb Company](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
AstraZeneca Provides Update On RECENTIN⢠Clinical Development Programme
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Pfizer Voluntarily Withdraws Lipitor Advertising Featuring Dr. Robert Jarvik
- Details
- Category: Pfizer
![Pfizer Pfizer](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Novartis Vaccines Institute for Global Health (NVGH) is the first institute with nonprofit mission
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Nycomed creates a leading specialty pharmaceutical player in dermatology
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
More Pharma News ...
- AstraZeneca To Appeal Judgment In Alabama Medical Pricing Case
- Shire plc accelerating new product sales drive revenue growth of 36%
- New price reductions for GSK antiretrovirals in the world's poorest countries
- Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
- Bayer and Onyx Provide Update on Phase III Trial of Nexavar®
- Trasylol® - One Thousand Lives A Month
- EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline